TRPC6 participates in the development of blood pressure variability increase in sino-aortic denervated rats

Yu Wang1, Ling Liu2, Hongmei Tao1

  • 1Department of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.

Heart and Vessels
|August 27, 2020
PubMed

Insights

Increased blood pressure variability (BPV) is linked to cardiovascular issues. This study shows that the TRPC6 channel, not TRPC3, plays a key role in raising BPV in rats after sino-aortic denervation.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Hypertension Research

Background:

  • Elevated blood pressure variability (BPV) is a significant predictor of cardiovascular morbidity and mortality.
  • Understanding the mechanisms driving BPV is crucial for developing targeted interventions.
  • The cation channel transient receptor potential canonical 6 (TRPC6) has been implicated in various cardiovascular diseases.

Purpose of the Study:

  • To investigate the role of TRPC6 in the development of increased BPV.
  • To determine if TRPC6 expression is altered in a rat model of elevated BPV.
  • To assess the functional impact of TRPC6 modulation on BPV.

Main Methods:

  • A rat model of increased BPV was established using sino-aortic denervation (SAD).
  • Hemodynamic parameters, including BPV, were measured non-invasively.
  • TRPC6 and TRPC3 expression levels in myocardial and thoracic aortic tissues were quantified using Western Blot, immunofluorescence, and qRT-PCR.
  • The effects of TRPC6 activation and inhibition on BPV were evaluated in SAD rats.

Main Results:

  • SAD rats exhibited significantly increased systolic and diastolic BPV without changes in mean blood pressure or heart rate.
  • Both mRNA and protein levels of TRPC6 were substantially elevated in the myocardium and thoracic aorta of SAD rats.
  • TRPC3 expression showed no significant changes.
  • Activation of TRPC6 exacerbated BPV, while inhibition attenuated it in a dose-dependent manner.

Conclusions:

  • TRPC6 expression is significantly upregulated in the myocardium and thoracic aorta following SAD.
  • TRPC6, but not TRPC3, appears to play a critical role in the development and maintenance of elevated BPV.
  • Targeting TRPC6 may offer a therapeutic strategy for managing BPV and associated cardiovascular risks.